Frontiers in Genetics | Cancer Genetics and Oncogenomics

Original Research

Published on 19 Dec 2024

A comprehensive analysis of vasculogenic mimicry related genes to predict the survival rate of HCC and its influence on the tumor microenvironment

in Cancer Genetics and Oncogenomics

Jingyun Wang
Rong Gao
Jian Qi
Yingru Xing
Bo Hong
Hongzhi Wang
Jinfu Nie

Frontiers in Genetics

doi 10.3389/fgene.2024.1437715

2,848 views
1 citation

Original Research

Published on 17 Dec 2024

Identification and validation the predictive biomarkers based on risk-adjusted control chart in gemcitabine with or without erlotinib for pancreatic cancer therapy

in Cancer Genetics and Oncogenomics

Aijun Zhao
Dongsheng Tu
Ye He
Liu Liu
Bin Wu
Yixing Ren

Frontiers in Genetics

doi 10.3389/fgene.2024.1497254

2,383 views

Original Research

Published on 09 Dec 2024

Integration of single-cell and bulk analysis reveals TBXAS1 as a key platelet-related gene causing poor prognosis in osteosarcoma

in Cancer Genetics and Oncogenomics

Han Liu
Wacili Da
Jianhua Mu
Xuanhong He
Zhuangzhuang Li
Taojun Gong
Jingjing Wang
Li Min
Minxun Lu
Chongqi Tu

Frontiers in Genetics

doi 10.3389/fgene.2024.1519529

2,467 views
2 citations

Original Research

Published on 06 Dec 2024

Real-world efficacy and safety of combined first-line treatment with PARP inhibitors and novel hormonal therapy in mCRPC patients with HRR gene mutations

in Cancer Genetics and Oncogenomics

Andong Guo
Chenrui Wu
Jishuang Cao
Kejia Zhu
Sentai Ding

Frontiers in Genetics

doi 10.3389/fgene.2024.1505163

1,999 views

Original Research

Published on 05 Dec 2024

Exploring the impact of deubiquitination on melanoma prognosis through single-cell RNA sequencing

in Cancer Genetics and Oncogenomics

Su Peng
Jiaheng Xie
Xiaohu He

Frontiers in Genetics

doi 10.3389/fgene.2024.1509049

2,053 views
1 citation

Original Research

Published on 05 Dec 2024

BIRC5 as a prognostic and diagnostic biomarker in pan-cancer: an integrated analysis of expression, immune subtypes, and functional networks

in Cancer Genetics and Oncogenomics

Guoyu Li
Yanghao Wang
Weizhou Wang
Guodong Lv
Xiang Li
Jingying Wang
Xiuyu Liu
Daolang Yuan
Shoujun Deng
Dingyun You

Frontiers in Genetics

doi 10.3389/fgene.2024.1509342

3,691 views
8 citations

Correction

Published on 04 Dec 2024

Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

in Cancer Genetics and Oncogenomics

Haiyang Zhao
Kexin Luo
Meihan Liu
Yuanze Cai
Siman Liu
Shijuan Li
Yongsheng Zhao
Hongpan Zhang

Frontiers in Genetics

doi 10.3389/fgene.2024.1531321

1,123 views

Review

Published on 29 Nov 2024

PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for

in Cancer Genetics and Oncogenomics

Sara Parola
Christoph Oing
Pasquale Rescigno
Salvatore Feliciano
Francesca Carlino
Luca Pompella
Antonella Lucia Marretta
Irene De Santo
Martina Viggiani
Margherita Muratore

Frontiers in Genetics

doi 10.3389/fgene.2024.1480417

2,447 views
2 citations

Original Research

Published on 29 Nov 2024

Gradient boosting reveals spatially diverse cholesterol gene signatures in colon cancer

in Cancer Genetics and Oncogenomics

Xiuxiu Yang
Debolina Chatterjee
Justin L. Couetil
Ziyu Liu
Valerie D. Ardon
Chao Chen
Jie Zhang
Kun Huang
Travis S. Johnson

Frontiers in Genetics

doi 10.3389/fgene.2024.1410353

2,119 views

Original Research

Published on 27 Nov 2024

Exploring the therapeutic potency of cryptotanshinone in cervical cancer: a multi-omics and network pharmacology approach

in Cancer Genetics and Oncogenomics

Zenghong Lu
Gangfeng Zhu
Xiaofei Feng
Yi Xiang
Cixiang Chen
Huiting Yuan
Zhixing Chen

Frontiers in Genetics

doi 10.3389/fgene.2024.1435132

2,430 views

Original Research

Published on 22 Nov 2024

Holliday junction recognition protein (HJURP) could reflect the clinical outcomes of lung adenocarcinoma patients, and impact the choice of precision therapy

in Cancer Genetics and Oncogenomics

Xixi Gao
Yingqing Zhang
Ming Zhang
Yuejiao Sun

Frontiers in Genetics

doi 10.3389/fgene.2024.1475511

3,273 views

Original Research

Published on 22 Nov 2024

Bioinformatics insights into the role of GFPT1 in breast invasive carcinoma: implications for tumor prognosis, immune modulation, and therapeutic applications

in Cancer Genetics and Oncogenomics

Jianghui Liang
Xiaolian Deng
Yingyi Zhang
Tianchi Fei
Muzi Ouyang
Chengjie Yu
Yang Xiang
Dongwei Jia
Fangfang Duan

Frontiers in Genetics

doi 10.3389/fgene.2024.1482929

2,574 views
2 citations

Original Research

Published on 14 Nov 2024

A scoring model based on bacterial lipopolysaccharide-related genes to predict prognosis in NSCLC

in Cancer Genetics and Oncogenomics

Nandi Bao
Xinxin Zhang
Chenyu Lin
Feng Qiu
Guoxin Mo

Frontiers in Genetics

doi 10.3389/fgene.2024.1408000

3,208 views
2 citations

Original Research

Published on 23 Oct 2024

Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

in Cancer Genetics and Oncogenomics

Haiyang Zhao
Kexin Luo
Meihan Liu
Yuanze Cai
Siman Liu
Shijuan Li
Yongsheng Zhao
Hongpan Zhang

Frontiers in Genetics

doi 10.3389/fgene.2024.1458047

2,843 views
1 citation

Original Research

Published on 22 Oct 2024

Elucidating macrophage scavenger receptor 1’s mechanistic contribution as a shared molecular mediator in obesity and thyroid cancer pathogenesis via bioinformatics analysis

in Cancer Genetics and Oncogenomics

Fangjian Shang
Zhe Xu
Haobo Wang
Bin Xu
Ning Li
Jiakai Zhang
Xuan Li
Zhen Zhao
Xi Zhang
Bo Liu

Frontiers in Genetics

doi 10.3389/fgene.2024.1483991

2,144 views
1 citation

Editorial

Published on 18 Oct 2024

Editorial: Precision oncology in the era of CRISPR-Cas9 technology

in Cancer Genetics and Oncogenomics

Athar Khalil

Frontiers in Genetics

doi 10.3389/fgene.2024.1506627

3,790 views
3 citations

Original Research

Published on 09 Oct 2024

Pan-cancer analysis and experimental validation of FPR3 as a prognostic and immune infiltration-related biomarker for glioma

in Cancer Genetics and Oncogenomics

Chenglin Ye
Peng Li
Boxu Chen
Yong Mo
Qianrong Huang
Qiuyun Li
Qinhan Hou
Ligen Mo
Jun Yan

Frontiers in Genetics

doi 10.3389/fgene.2024.1466617

3,946 views
2 citations

Original Research

Published on 08 Oct 2024

Identification of plasma exosomal lncRNA as a biomarker for early diagnosis of gastric cancer

in Cancer Genetics and Oncogenomics

Ye Wei
Xuming Hu
Shuai Yuan
Yue Zhao
Chunhui Zhu
Mingzhou Guo
Hengmi Cui

Frontiers in Genetics

doi 10.3389/fgene.2024.1425591

2,375 views

Original Research

Published on 03 Oct 2024

Prognostic implications of metabolism-related genes in acute myeloid leukemia

in Cancer Genetics and Oncogenomics

Na Ren
Jianan Wang
Ruibing Li
Chengliang Yin
Mianyang Li
Chengbin Wang

Frontiers in Genetics

doi 10.3389/fgene.2024.1424365

3,047 views
3 citations

Brief Research Report

Published on 27 Sep 2024

Multi-omic analysis of longitudinal acute myeloid leukemia patient samples reveals potential prognostic markers linked to disease progression

in Cancer Genetics and Oncogenomics

Nisar Ahmed
Irene Cavattoni
William Villiers
Chiara Cugno
Sara Deola
Borbala Mifsud

Frontiers in Genetics

doi 10.3389/fgene.2024.1442539

3,379 views
4 citations

Editorial

Published on 27 Sep 2024

Editorial: The diversified role of mitochondria in cancer

in Cancer Genetics and Oncogenomics

Siyuan Song
Qingqing Xia
Yu’e Liu
Kuo Chen
Fengqian Chen
Jin Zhang
Yi Wang

Frontiers in Genetics

doi 10.3389/fgene.2024.1494075

2,389 views
1 citation

Original Research

Published on 23 Sep 2024

Comprehensive pan-cancer analysis and experiments revealed R3HDM1 as a novel predictive biomarker for prognosis and immune therapy response

in Cancer Genetics and Oncogenomics

Jiawei Liu
Zhitong Bing
Junling Wang

Frontiers in Genetics

doi 10.3389/fgene.2024.1404348

4,299 views
2 citations

Original Research

Published on 23 Sep 2024

A comprehensive in silico analysis and experimental validation of miRNAs capable of discriminating between lung adenocarcinoma and squamous cell carcinoma

in Cancer Genetics and Oncogenomics

Zahra Javanmardifard
Saeid Rahmani
Hadi Bayat
Hanifeh Mirtavoos-Mahyari
Mostafa Ghanei
Seyed Javad Mowla

Frontiers in Genetics

doi 10.3389/fgene.2024.1419099

3,038 views
3 citations

Original Research

Published on 19 Sep 2024

Driver gene alterations in NSCLC patients in southern China and their correlation with clinicopathologic characteristics

in Cancer Genetics and Oncogenomics

Lingna Deng
Jinbang Li
Zhanlong Qiu
Yanfen Wang

Frontiers in Genetics

doi 10.3389/fgene.2024.1455502

3,191 views
2 citations

1,180 articles

articles

A comprehensive analysis of vasculogenic mimicry related genes to predict the survival rate of HCC and its influence on the tumor microenvironment

Identification and validation the predictive biomarkers based on risk-adjusted control chart in gemcitabine with or without erlotinib for pancreatic cancer therapy

Integration of single-cell and bulk analysis reveals TBXAS1 as a key platelet-related gene causing poor prognosis in osteosarcoma

Real-world efficacy and safety of combined first-line treatment with PARP inhibitors and novel hormonal therapy in mCRPC patients with HRR gene mutations

Exploring the impact of deubiquitination on melanoma prognosis through single-cell RNA sequencing

BIRC5 as a prognostic and diagnostic biomarker in pan-cancer: an integrated analysis of expression, immune subtypes, and functional networks

Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for

Gradient boosting reveals spatially diverse cholesterol gene signatures in colon cancer

Exploring the therapeutic potency of cryptotanshinone in cervical cancer: a multi-omics and network pharmacology approach

Holliday junction recognition protein (HJURP) could reflect the clinical outcomes of lung adenocarcinoma patients, and impact the choice of precision therapy

Bioinformatics insights into the role of GFPT1 in breast invasive carcinoma: implications for tumor prognosis, immune modulation, and therapeutic applications

A scoring model based on bacterial lipopolysaccharide-related genes to predict prognosis in NSCLC

Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

Elucidating macrophage scavenger receptor 1’s mechanistic contribution as a shared molecular mediator in obesity and thyroid cancer pathogenesis via bioinformatics analysis

Editorial: Precision oncology in the era of CRISPR-Cas9 technology

Pan-cancer analysis and experimental validation of FPR3 as a prognostic and immune infiltration-related biomarker for glioma

Identification of plasma exosomal lncRNA as a biomarker for early diagnosis of gastric cancer

Prognostic implications of metabolism-related genes in acute myeloid leukemia

Multi-omic analysis of longitudinal acute myeloid leukemia patient samples reveals potential prognostic markers linked to disease progression

Editorial: The diversified role of mitochondria in cancer

Comprehensive pan-cancer analysis and experiments revealed R3HDM1 as a novel predictive biomarker for prognosis and immune therapy response

A comprehensive in silico analysis and experimental validation of miRNAs capable of discriminating between lung adenocarcinoma and squamous cell carcinoma

Driver gene alterations in NSCLC patients in southern China and their correlation with clinicopathologic characteristics